Project Grant R41AG085773
- Federal Project Grant Award Summary Advanced Brain Monitoring, Inc. received a $690,899 Project Grant awarded September 16, 2025, by the National Institute on Aging under the Aging Research program (CFDA 93.866) to validate and deploy a mobile electroencephalography (EEG) platform for objective assessment of neurocognitive deficits associated with post-acute sequelae of COVID-19 (PASC), commonly referred to as long COVID. The project, with completion targeted for May 31, 2027, focuses on...
- Grant Award Summary The National Institute on Aging awarded a $578,856 Project Grant to Washington University (awarded February 15, 2026; completion January 31, 2031) under the Aging Research program (CFDA 93.866) to investigate the relationship between sleep and neurodegenerative disease, specifically tau-related pathology. The primary deliverable is research demonstrating whether sleep enhancement can reinforce neural homeostatic set-points—particularly "criticality," an optimal...
- Federal Project Grant Award Summary Proactive Life Inc. received a $499,963 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded on September 20, 2025, with a completion date of September 19, 2026. The company is developing and validating SleepSpace AI, a fully automated Internet of Things (IoT)-based cognitive behavioral therapy for insomnia (CBTI) system designed to improve sleep quality and cognitive function in older adults. The system...
- Federal Project Grant Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Massachusetts General Hospital a Project Grant of $266,541 (Award Date: May 1, 2026; Completion Date: April 30, 2028) under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct longitudinal research on sleep electroencephalographic (EEG) signals and their relationship to cognitive function and brain state changes. The project will analyze existing data collected under highly controlled...
- The National Institute on Aging (NIA) awarded Brigham & Women's Hospital Inc. a $2,576,936 Project Grant under the Aging Research federal grant program (CFDA 93.866) to characterize the variability in sleep spindle activity across a population and evaluate the use of sleep spindle dynamics as biomarkers for Alzheimer's disease, mild cognitive impairment, and trisomy 21. The 3-year project will develop statistical models and methods to analyze sleep spindle patterns and their relationship...
- Federal Project Grant Award Summary Oscilloscape, Inc. (operating as Oscillo Biosciences) received a $1.4M Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866) effective September 20, 2025, through September 19, 2026. The grant funds development and clinical testing of SYNG (SynchronyGamma), an innovative wearable digital health device designed to treat Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in aging adults. The device...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded Massachusetts General Hospital a $868,901 Project Grant on March 1, 2026, under the Aging Research program (CFDA 93.866) to conduct the Sleep and Circadian Rhythm Biomarkers of Postoperative Neurocognitive Recovery (SLEEP-POD2) study through January 31, 2031. This longitudinal, multisite research initiative enrolls 400 older adult patients (age 65+) undergoing non-cardiac surgery across Boston and Baltimore to...
- Federal Project Grant Award Summary Boston University Medical Campus received a $323,825 Project Grant awarded January 1, 2026, under the National Institute on Aging's Aging Research program (CFDA 93.866) to support research on early detection of Alzheimer's disease and related dementias (ADRD). The award, with completion scheduled for December 31, 2027, funds the development of advanced artificial intelligence (AI) tools and novel analytical methods for digital neuropsychological testing,...
- Grant Award Summary The National Institute on Aging awarded a $218,410 Project Grant to the Regents of the University of Michigan under the Aging Research program (CFDA 93.866) effective September 16, 2025, with completion expected by June 30, 2027. The award funds research investigating the relationship between sleep disturbances and age-related memory loss, specifically examining how sleep deprivation alters hippocampal excitatory/inhibitory (E/I) balance through effects on...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $1.238 million Project Grant to the University of California Irvine effective February 1, 2026, through January 31, 2031, under the Aging Research program (CFDA 93.866). This research project delivers longitudinal neuroimaging and biomarker analysis services designed to elucidate the relationships between Alzheimer's disease (AD) pathophysiology, local sleep expression patterns, and sleep-dependent memory function across...
A MACHINE LEARNING ALGORITHM TO ASSESS FUNCTIONAL "BRAIN AGE" FROM AN IN-HOME EEG SLEEPBAND - 1 PROJECT SUMMARY 2 HUMANS ARE LIVING LONGER, RESULTING IN OUR BODIES OUTLIVING OUR BRAINS. ALTHOUGH BEHAVIORAL CHANGES AND BETTER 3 MANAGEMENT OF HEALTH CONDITIONS CAN HELP REVERSE OR SLOW DOWN PREMATURE DECLINE IN BRAIN FUNCTION, PRE- 4 SYMPTOMATIC ADULTS ARE NOT IDENTIFIED EARLY ENOUGH WHEN THESE CHANGES WOULD MAKE THE MOST SIGNIFICANT POSITIVE 5 IMPACT. EFFECTIVE INTERVENTION REQUIRES EARLY DETECTION BEFORE IRREVERSIBLE BRAIN DAMAGE OCCURS, BUT THERE IS A LACK 6 OF OBJECTIVE, SCALABLE TOOLS TO ASSESS BRAIN FUNCTION IN PRE-SYMPTOMATIC ADULTS. 7 8 BRAIN AGE (BA) IS A BIOMARKER THAT CAN BE USED FOR EARLY DETECTION OF DETERIORATION IN BRAIN FUNCTION. BA REFLECTS 9 AN INDIVIDUAL'S AGE-ADJUSTED STRUCTURAL AND/OR FUNCTIONAL BRAIN CHARACTERISTICS AND HAS BEEN SHOWN TO DETECT 10 COGNITIVE IMPAIRMENT. WHILE EFFECTIVE, THE COST AND INCONVENIENCE OF CURRENT ASSESSMENT METHODS (E.G., MRI, 11 POLYSOMNOGRAPHY) PREVENT WIDESPREAD USAGE OF BA AS A BIOMARKER. THEREFORE, THERE IS A CLEAR UNMET NEED FOR 12 A NEW METHOD FOR ASSESSING BA. 13 14 NEUROGENECES' BA MACHINE LEARNING (ML) MODEL, USING AT-HOME SLEEP DATA, WILL PROVIDE AN OBJECTIVE AND 15 INTERPRETABLE MEASURE OF AGE-ADJUSTED BRAIN FUNCTION. IN THIS PHASE I STTR PROJECT, NEUROGENECES WILL EXPAND 16 THE DATASET OF SLEEP RECORDINGS BY CONDUCTING A HUMAN SUBJECT STUDY AND VALIDATE THE FEASIBILITY OF A ML MODEL 17 THAT ACCURATELY PREDICTS BIOLOGICAL BA IN COGNITIVELY HEALTHY ADULTS USING AN AT-HOME SLEEP EEG HEADBAND.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 8/26/25 | ||
| Not listed | $0 | 6/25/25 | ||
| Not listed | $0 | 6/25/25 | ||
| Not listed | $295.0k | 9/7/23 |